Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Parkinson disease protein 7 (DJ-1, encoded by the PARK7 gene) is a ubiquitous, highly conserved protein best known for its role in protecting cells from oxidative stress, with a particularly crucial role in neurons. It is a dimeric member of the peptidase C56 family but itself lacks classical protease activity. DJ-1 functions as an oxidative stress sensor via its highly reactive cysteine residues (notably Cys106), modulating gene expression and antioxidant defense, influencing dopamine biosynthesis, and helping maintain cellular homeostasis. Mutations in DJ-1 cause autosomal recessive early-onset Parkinson’s disease due to loss of protective function, and altered DJ-1 activity or oxidation status is implicated in both familial and sporadic Parkinson’s. DJ-1 may also act as an adapter in protein and RNA metabolism complexes, and its weak enzymatic (glyoxalase) activity has been debated. While DJ-1 has oncogenic potential in some contexts, especially in Ras/MAPK-dependent transformation, its primary therapeutic relevance is in neurodegeneration, especially as a biomarker and potential future target for disease modulation[1][2][3][5][7][8][9].
Drugs targeting DJ-1 would likely aim to stabilize the protein, restore its antioxidant function, or modulate oxidative stress pathways. Experimental therapies focus on redox homeostasis or gene/protein stabilization[5][8][9].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Parkinson disease protein 7 (DJ-1).